Tech Company Financing Transactions
Forbion Funding Round
On 4/19/2023, Forbion raised $1.5 billion in funding from Forbion Growth Opportunities Fund II and Forbion Ventures Fund VI.
Transaction Overview
Company Name
Announced On
4/19/2023
Transaction Type
Venture Equity
Amount
$1,500,000,000
Round
Undisclosed
Investors
Forbion Growth Opportunities Fund II (Lead Investor)
Proceeds Purpose
The two funds meet the needs of distinct segments of the market. The Forbion Ventures Fund VI is focused on building companies at an earlier stage of development and the Forbion Growth Opportunities Fund II supports the expansion of late-stage life sciences companies.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Gooimeer 2-35
Naarden, 1411 DC
NL
Naarden, 1411 DC
NL
Phone
Website
Email Address
Overview
Forbion is a leading European venture capital firm that helps companies bridge research and development through the team's expertise in drug development and company building. Forbion is signatory to the United Nations Principles for Responsible Investment further demonstrating our philosophy that investments in companies should positively impact the health and well-being of patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vincent Houten
Chief Technical Officer
Martien Osch
Co-Founder
Sander Slootweg
Browse more venture capital transactions:
Prev: 4/19/2023: Dasera venture capital transaction
Next: 4/19/2023: Trullion venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs